l 447 -Grumbach, University of CaliforEia, San Francisco, Dept. of Pediatrics, San Francisco Adrenoleukodystrophy (ALD) is a well-described cause of familial primary adrenal insufficiency in which neurological symptoms may be absent for many years. While the spectrum of adrenal insufficiency in ALD is variable, primary impairment of glucocorticoid secretion may resemble familial ACTH unresponsiveness, a different rare form of adrenal insufficiency. To distinguish ALU from other forms of familial adrenal insufficiency, we carried out the following studies in 3 male patients (age 11-16 yr): measurement of plasma saturated very-long-chain fatty acids (C26 and C26lC22 ratio), adrenal antibodies (AAb), plasma renin activity (PRA), and computerized tomography (CT) or magnetic resonance (MR) studies of the CNS. C26 was elevated above control in all three patients, 2.14 + 1.21 pglml, mean 2 S.D. (normal 0.33 + 0.18) as was the C26/C22 ratio, 0.04 + 0.01 (normal 0.01 + 0.01), consistent with the diagnosis of ALD. AAb were undetectable in all patients. PRA was normal in one patient and elevated in two. Neurological examinations were unremarkable in all patients, without evidence of leukodystrophy on CT or MR scans. This study illustrates the need to consider ALD in the differential diagnosis of childhood familial primary adrenal insufficiency in the absence of neurological symptoms. Furthermore, it is important to recognize that ALD may present with isolated glucorticoid deficiency and thus may mimic ACTH unresponsiveness, which has separate genetic, prognostic, and therapeutic considerations. Precocious puberty was observed in a preterm (27 wks post-conceptional age -PCA) female. A t 41 wks PCA, estradiol (E2) levels were elevated (282 pg/ml).
By 1 3 months PCA, E 2 decreased spontaneously (18 pg/ml) and pubertal changes regressed. However, pelvic ultrasonography revealed the development of ovarian cysts. I n order t o interpret these findings and determine their significance, w e studied 6 normal preterm female infants (PCA 2 3 4 wks) during the first month o f postnatal life. W e measured: a ) E2 -max > 30,000 pg/ml on d a y o f birth (DOB), b) LH -max 196 mIu/ml on DQB, c) FSH -max 125.2 mIu/ml 3 w k s after birth, d) 17-hydroxyprogesterone -m a x 4320 ng/dl on DOB, and e ) DHEA-S -max 429 A 450 of Pediatrics., Stanford University Medical Center, Stanford, CA.
Buffalo Rat Liver 3A (BRL) and 18,54-SF cells are two rat tumor cell lines which have been maintained continuously i n serum-free media. Both cell lines secrete rat IGF-II (>50ng/ml in three day conditioned media) and have no detectable rlGF-I peptide by RIA. The experimental design was to: 1) demonstrate that lack of rlGF-I production was due to absent transcription of rlGF-I mRNA, and 2) to compare BRL, 18,54-SF and rat liver IGF-II RNA sizes and abundance patterns on Northern blots. RNA was prepared by the guainidine thiocyanatelLiCl technique. Polyadenylated RNA (A+) was separated from nonpolyadenylated RNA (A-) by ol~go dT cellulose chromatography, sued on for~naldehvde-actarose aels and transferred to nvlon membranes IGF RNA sequences wers detected either by hybridization io in vrtro transcribed cRNA specilic to each strand, or to in v~tro hexamer primed DNA at a specific actlvlly > 109 cpmkg. Probes were to i ) the carboxyl terminal E peptides and 3 ' nontranslated regions which are highly specif~c for each of the two IGF species and i i ) the 5' reg:on of IGF-I thus allowinD detection of both IGF-I soliciw variants. Non-s~ecilic bindina was reduced by final washing in 0 . 1~ S S C '~~ 6 1~. IGF-I ~R N A ' C O U~~ not bg detected i n BRL nor 18.54-SF cells but was easily detected i n adult rat liver as 1800 and 660 base major species with -6 intermediate forms. IGF-II mRNA was detected by the 3 ' cDNA and 3 ' anti-sense cRNA probes; no species were found to hybridize with the 3 ' sense cRNA, indicating that all mRNAs are in the usual 5' to 3' sense orientation. The BRL and 18,54-SF cells had multiple IGF-II forms (>lOkb, 7.0kb, 5.8kb, 4.4kb, 3.5kb, 3.0kb, 2.7kb . 2.5kb, 1.8kb and 1.lkb). The most abundant form i n BRL cells was 5.8kb i n length and polyadenylated. The predominant form i n 18,54-SF cells was 4.4kb in length and this was the most abundant A+ form; additionally an A-form at 1 .lkb was observed. AduH rat liver had no detectable IGF-II RNA sequences. These data demonstrate that regulated expression occurs at the level of transcription. The presence of rlGF-II mRNA and peptide i n the absence of rlGF-I mRNA and peptide, coupled with the ability to grow in serum free defined media support IGF-II as being a critical growth factor i n these cell lines. We determined whether co-localized adrenal opiate peptides are also subject to hormonal control. Adrenal cortical destruction (mitotane) decreased baseline leuenkephalin (LEU) levels in vivo by 38% (p<0.05).
To examine cellular mechanisms, rat medullae were grown as explants in glucocorticoid deficient medium. LEU levels start low then increase in a dose-depend t fashion following corticosterone -5" replacement (zero to 10 M ) .
Effects of glucocorticoids could be blocked by alkylating (CM-21, DM-21) or non-alkylating (cortexolone) receptor antagonists added to corticosterene containing medium.
Moreover, inhibition of glucocorticoid receptor translocation to the nucleus (cytochalasin B) also blocked the hormone effect.
In addition, a 13 out of 17 nucleic acid match for a putative glucocorticoid receptor binding site was identified in intron A of the rat preproenkephalin genome. These observations are consistent with dual hormonal, and transsynaptic regulation (La Gamma, et a1 PNAS 82:8252, 1985) of opiate biosynthetic processes. Therefore, similar to CA, LEU exhibits significant transmitter plasticity which may serve an adaptive role in modulating complex biochemical and behavioral responses (eg. during stress or development) with exquisite precision. Supported in part by the American Heart Association.
